Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions
Open accessThe DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Abstract
Signal transduction pathways use protein kinases for the modification of protein function by phosphorylation. A major question in the field is how protein kinases achieve the specificity required to regulate multiple cellular functions. Here we review recent studies that illuminate the mechanisms used by three families of Ser/Thr protein kinases to achieve substrate specificity. These kinases rely on direct docking interactions with substrates, using sites distinct from the phospho-acceptor sequences. Docking interactions also contribute to the specificity and regulation of protein kinase activities. Mitogen-activated protein kinase (MAPK) family members can associate with and phosphorylate specific substrates by virtue of minor variations in their docking sequences. Interestingly, the same MAPK docking pocket that binds substrates also binds docking sequences of positive and negative MAPK regulators. In the case of glycogen synthase kinase 3 (GSK3), the presence of a phosphate-binding site allows docking of previously phosphorylated (primed) substrates; this docking site is also required for the mechanism of GSK3 inhibition by phosphorylation. In contrast, non-primed substrates interact with a different region of GSK3. Phosphoinositide-dependent protein kinase-1 (PDK1) contains a hydrophobic pocket that interacts with a hydrophobic motif present in all known substrates, enabling their efficient phosphorylation. Binding of the substrate hydrophobic motifs to the pocket in the kinase domain activates PDK1 and other members of the AGC family of protein kinases. Finally, the analysis of protein kinase structures indicates that the sites used for docking substrates can also bind N- and C-terminal extensions to the kinase catalytic core and participate in the regulation of its activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, the PNT domains are docking modules, interacting with complementary docking sites on the kinases (103, 104).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yung, Y., Yao, Z., Aebersold, D. M., Hanoch, T., & Seger, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105995200 · Cited by 47
RetractedThe protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186 · cited 4×
“and Cohen, P. (2001) GSK3 takes centre stage more than 20 years after its discovery.”
BackgroundInfluentialKnighton, D. R., Zheng, J., Ten Eyck, L. F., Ashford, V. A., Xuong, N.-H., Taylor, S. S., & Sowadski, J. M. (1991) · Science · doi:10.1126/science.1862342 · Cited by 1,759
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,752
The PI3K‒PDK1 connection: more than just a road to PKB
Vanhaesebroeck, B., & Alessi, D. R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460561 · Cited by 1,644
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex
Jeffrey, P. D., Russo, A. A., Polyak, K., Gibbs, E., Hurwitz, J., Massagué, J., & Pavletich, N. P. (1995) · Nature · doi:10.1038/376313a0 · Cited by 1,436
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Cited by
Items 101–200 of 337
Phosphosite Mapping of P-type Plasma Membrane H+-ATPase in Homologous and Heterologous Environments
Rudashevskaya, E. L., Ye, J., Jensen, O. N., Fuglsang, A. T., & Palmgren, M. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.307264 · Cited by 78
New Insights into the p38γ and p38δ MAPK Pathways
Risco, A., & Cuenda, A. (2012) · Journal of Signal Transduction · doi:10.1155/2012/520289 · Cited by 70
“Moreover, there are two important structural requirements for selective activation of p38MAPK isoforms by MKKs: docking sequences in the N-terminus of the MKK and isoform-specific sequences of the p38MAPK isoforms within the activation loop [13, 24, 25].”
Vomastek, T., Iwanicki, M., Burack, R., Tiwari, D., Kumar, D., Parsons, J. T., Weber, M. J., & Nandicoori, V. K. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00925-08 · Cited by 72
“The first is a KIM (kinase-interacting motif, also known as a D domain) which consists of a stretch of basic amino acids surrounded by aliphatic hydrophobic residues (leucines, isoleucines, or valines) (3, 38, 42, 50).”
BackgroundZeke, A., Bastys, T., Alexa, A., Garai, Á., Mészáros, B., Kirsch, K., Dosztányi, Z., Kalinina, O. V., & Reményi, A. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156269 · Cited by 64
“They mainly recognize their substrates not with the catalytic site but with auxiliary docking surfaces on their kinase domains (Tanoue et al, 2000; Biondi & Nebreda, 2003).”
Quantitative Analysis of ERK2 Interactions with Substrate Proteins
Burkhard, K. A., Chen, F., & Shapiro, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.177899 · Cited by 62
Lopez-Garcia, L. A., Schulze, J. O., Fröhner, W., Zhang, H., Süß, E., Weber, N., Navratil, J., Amon, S., Hindie, V., Zeuzem, S., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.08.010 · Cited by 65
Self-citationAllosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain
Craig, A., Scott, M., Burch, L., Smith, G., Ball, K., & Hupp, T. (2003) · EMBO reports · doi:10.1038/sj.embor.embor901 · Cited by 64
“Such docking sites have been observed previously for CDK2 (Luciani et al., 2000), PDK1, MAPK and GSK3 (Biondi & Nebreda, 2003).”
BackgroundGlycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1
Zhang, M., Zhang, J., Chen, X., Cho, S.-J., & Chen, X. (2013) · Genes & Development · doi:10.1101/gad.221739.113 · Cited by 69
Ezrin activation by LOK phosphorylation involves a PIP2-dependent wedge mechanism
Pelaseyed, T., Viswanatha, R., Sauvanet, C., Filter, J. J., Goldberg, M. L., & Bretscher, A. (2017) · eLife · doi:10.7554/elife.22759 · Cited by 62
“As is seen with some other serine/threonine kinases (Biondi and Nebreda, 2003; Sharrocks et al., 2000; Ubersax and Ferrell, 2007), we have also identified a distal docking site within residues 520–530 in the ezrin-CTD, required for the efficient phosphorylation of T567 by either LOK or the isolated…”
BackgroundProgress in the evaluation of CDK inhibitors as anti-tumor agents
McInnes, C. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.06.012 · Cited by 65
Non-ATP competitive protein kinase inhibitors as anti-tumor therapeutics
Kirkland, L. O., & McInnes, C. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.022 · Cited by 68
Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis
Paunovic, V., & Harnett, M. M. (2013) · Drugs · doi:10.1007/s40265-013-0014-6 · Cited by 61
“Interaction of an MAPK and its downstream substrate or upstream regulator is dependent on docking motif binding sites [25, 26] which are, in part, responsible for conferring specificity amongst the MAPK signalling modules [27].”
BackgroundA Summary of Computational Resources for Protein Phosphorylation
Xue, Y., Gao, X., Cao, J., Liu, Z., Jin, C., Wen, L., Yao, X., & Ren, J. M. (2010) · Current Protein and Peptide Science · doi:10.2174/138920310791824138 · Cited by 65
“For more detailed information on algorithms, model construction, and mechanisms of phosphorylation specificity, we recommend several excellent reviews [18, 22, 26-28, 30-34, 38, 39].”
BackgroundMethodGuzmán, E. A., Johnson, J. D., Linley, P. A., Gunasekera, S. E., & Wright, A. E. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9422-6 · Cited by 62
“Since Manzamine A was suspected to act upon the MEK/ERK signaling pathway based on cytoblot screening, the MEK inhibitor U0126 was used as a positive control at a previously reported concentration [2].”
Chou, H.-Y., Howng, S.-L., Cheng, T.-S., Hsiao, Y.-L., Lieu, A., Loh, J., Hwang, S.-L., Lin, C.-C., Hsu, C.-M., Wang, C., et al. (2006) · Biochemistry · doi:10.1021/bi061147r · Cited by 63
The Activity of HDAC8 Depends on Local and Distal Sequences of Its Peptide Substrates
Gurard-Levin, Z. A., & Mrksich, M. (2008) · Biochemistry · doi:10.1021/bi800053v · Cited by 55
“Several other classes of enzymes have been reported to utilize exosites in the recognition of their polypeptide substrates, including matrix metalloproteinases (MMPs) (36), kinases (37), and the thrombin protease (38).”
BackgroundKUMA, Y., CAMPBELL, D. G., & CUENDA, A. (2004) · Biochemical Journal · doi:10.1042/bj20031559 · Cited by 55
Craig, A. L., Chrystal, J. A., Fraser, J. A., Sphyris, N., Lin, Y., Harrison, B. J., Scott, M. T., Dornreiter, I., & Hupp, T. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01595-06 · Cited by 54
“Although the information required for a protein kinase to phosphorylate a target is generally thought to occur within the primary phosphorylation site, growing evidence points to a second determinant of specificity involving enzyme docking (5).”
BackgroundComputational identification and phylogenetic analysis of the MAPK gene family in Oryza sativa
Liu, Q., & Xue, Q. (2007) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2006.12.011 · Cited by 56
Zhang, T., Jia, N., Fei, E., Wang, P., Liao, Z., Ding, L., Yan, M., Nukina, N., Zhou, J., & Wang, G. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.041 · Cited by 52
“[1] R.”
Aponte, A. M., Phillips, D. J., Harris, R. A., Blinova, K., French, S. A., Johnson, D., & Balaban, R. S. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)05004-6 · Cited by 53
“With regard to non-specific phosphorylation by kinases, the kinase selectivity is based on both the phosphorylation site sequence (Yaffe et al., 2001) as well as docking region for the kinase on the target protein (Biondi and Nebreda, 2003), but does not result in complete exclusion.”
BackgroundHsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation
Yun, B.-G., & Matts, R. L. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.006 · Cited by 56
A Proteomic Approach for Comprehensively Screening Substrates of Protein Kinases Such as Rho-Kinase
Amano, M., Tsumura, Y., Taki, K., Harada, H., Mori, K., Nishioka, T., Kato, K., Suzuki, T., Nishioka, Y., Iwamatsu, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008704 · Cited by 51
“In addition to the active center, several kinases, such as MAPK, GSK3 and PDK1, have been reported to associate with substrates through extra docking sites, which may confer substrate specificity and facilitate phosphorylation efficiency [6].”
BackgroundMae inhibits Pointed‐P2 transcriptional activity by blocking its MAPK docking site
Qiao, F., Harada, B., Song, H., Whitelegge, J., Courey, A. J., & Bowie, J. U. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600924 · Cited by 41
“In the last decade, several short amino-acid sequence motifs have been found to be MAPK docking sites based on studies of different transcription factors (Holland and Cooper, 1999; Jacobs et al, 1999; Biondi and Nebreda, 2003; Yang et al, 2003).”
BackgroundExamining Docking Interactions on ERK2 with Modular Peptide Substrates
Lee, S., Warthaka, M., Yan, C., Kaoud, T. S., Ren, P., & Dalby, K. N. (2011) · Biochemistry · doi:10.1021/bi201103b · Cited by 47
“The D-recruitment site (DRS) and the Frecruitment site (FRS) bind D-sites and F-sites respectively (5-8).”
BackgroundMethodInfluentialRegulation of the transcriptional activity of nuclear receptors by the MEK/ERK1/2 pathway
Zassadowski, F., Rochette‐Egly, C., Chomienne, C., & Cassinat, B. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.08.003 · Cited by 60
Perry, J. J. P., Harris, R. M., Moiani, D., Olson, A. J., & Tainer, J. A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.06.005 · Cited by 51
“Where defined, this insert can be critical to substrate or protein partner binding.(57,58) The function of this insert in p38α is being characterized, with initial reports suggesting a role in binding FXF motifs(20) or arachidonic acid metabolites.”
Qvit, N., Joshi, A. U., Cunningham, A. D., Ferreira, J. C. B., & Mochly‐Rosen, D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.711630 · Cited by 51
“These latter interactions have often been found to increase the affinity of kinases for their substrates (44, 45).”
BackgroundContribution of Non-catalytic Core Residues to Activity and Regulation in Protein Kinase A
Yang, J., Kennedy, E. J., Wu, J., Deal, M. S., Pennypacker, J., Ghosh, G., & Taylor, S. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805862200 · Cited by 43
Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection
Park, B. K., Kim, D., Park, S., Maharjan, S., Kim, J.-S., Choi, J.-K., Akauliya, M., Lee, Y., & Kwon, H. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.226 · Cited by 49
“Because MAPK phosphorylates serine or threonine residues (Biondi and Nebreda, 2003; Matsuyama et al, 2020) and because serine phosphorylation contributes to maximal STAT1 and STAT3 activity (Yokogami et al.”
Large-Scale Identification of Phosphorylation Sites for Profiling Protein Kinase Selectivity
Imamura, H., Sugiyama, N., Wakabayashi, M., & Ishihama, Y. (2014) · Journal of Proteome Research · doi:10.1021/pr500319y · Cited by 48
Bolaños-García, V. M. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3696-6 · Cited by 52
Agassandian, M., Zhou, J., Tephly, L. A., Ryan, A. J., Carter, A. B., & Mallampalli, R. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412409200 · Cited by 47
Interfering with MAP Kinase Docking Interactions: Implications and Perspectives for the p38 Route
Mayor, Jr., Jurado-Pueyo, M., Campos, P. M., & Murga, C. (2007) · Cell Cycle · doi:10.4161/cc.6.5.3920 · Cited by 44
Li, Q., Al‐Ayoubi, A. M., Guo, T.-L., Zheng, H., Sarkar, A., Nguyen, T., Eblen, S. T., Grant, S., Kellogg, G. E., & Zhang, S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.057 · Cited by 48
Friedman, J. S., Khanna, H., Swain, P. K., DeNicola, R., Cheng, H., Mitton, K. P., Weber, C. H., Hicks, D., & Swaroop, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408298200 · Cited by 43
Melino, S., Nepravishta, R., Bellomaria, A., Marco, S. D., & Paci, M. (2008) · Biochemistry · doi:10.1021/bi801407w · Cited by 44
“This exosite, like other enzymes (53-55), might interact with molecules,”
Duarte, M. L., Pena, D. A., Ferraz, F. A. N., Berti, D. A., Sobreira, T. J. P., Costa‐Junior, H. M., Baqui, M. M. A., Disatnik, M., Xavier‐Neto, J., de Oliveira, P. S. L., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005412 · Cited by 45
The Arabidopsis thaliana GSK3/Shaggy like kinase AtSK3-2 modulates floral cell expansion
Claisse, G., Charrier, B., & Kreis, M. E. (2007) · Plant Molecular Biology · doi:10.1007/s11103-007-9138-y · Cited by 48
“…accordance with several other biochemical studies conducted with wild-type GSK3b or GSK3b-R96A mutant proteins using either the same substrate as above (i.e. eiF2B) or known targets of GSK3b (i.e. GS, b-catenin) (see Welsh et al. 1997; Frame et al 2001; Hagen et al. 2002; Biondi and Nebreda 2003).”
ResultDesigning New Cellular Signaling Pathways
Pryciak, P. M. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.01.011 · Cited by 45
Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity
Moore, N. L. T., Narayanan, R., & Weigel, N. L. (2007) · Steroids · doi:10.1016/j.steroids.2006.11.025 · Cited by 44
de la Cova, C., & Greenwald, I. (2012) · Genes & Development · doi:10.1101/gad.203703.112 · Cited by 45
“5A; Jacobs et al. 1999; Biondi and Nebreda 2003).”
BackgroundLi, P., Ji, Y., Li, Y., Yan, Y., & Zhou, Y. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01476-2 · Cited by 42
The Structure of the MAP2K MEK6 Reveals an Autoinhibitory Dimer
Min, X., Akella, R., He, H., Humphreys, J. M., Tsutakawa, S. E., Lee, S., Tainer, J. A., Cobb, M. H., & Goldsmith, E. J. (2009) · Structure · doi:10.1016/j.str.2008.11.007 · Cited by 41
“This autoinhibitory dimer of MEK6, and by inference MEK1/2 dimers, add to a growing list of unanticipated allosteric regulatory mechanisms that confer pathway specificity in MAP kinase modules and other protein kinases (Goldsmith et al., 2007; Biondi and Nebreda, 2003).”
BackgroundLisa, M., Gil, M., André-Leroux, G., Barilone, N., Durán, R., Biondi, R. M., & Alzari, P. M. (2015) · Structure · doi:10.1016/j.str.2015.04.001 · Cited by 38
Self-citationGRK2 Activation by Receptors: Role of the Kinase Large Lobe and Carboxyl-Terminal Tail
Sterne‐Marr, R., Leahey, P. A., Bresee, J., Dickson, H. M., Ho, W. Y., Ragusa, M. J., Donnelly, R. M., Amie, S. M., Krywy, J. A., Brookins-Danz, E. D., et al. (2009) · Biochemistry · doi:10.1021/bi900151g · Cited by 38
“This is common for protein kinases, which often rely on “docking sites” to achieve high affinity and selectivity for their targets (39).”
BackgroundΠολυχρονόπουλος, Σ., Verykokakis, M., Yazicioglu, M. N., Sakarellos‐Daitsiotis, M., Cobb, M. H., & Mavrothalassitis, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605185200 · Cited by 57
The present and the future of motif-mediated protein–protein interactions
Seo, M., & Kim, P. M. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.04.005 · Cited by 38
Won, A. P., Garbarino, J. E., & Lim, W. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016337108 · Cited by 41
Molina, D. M., Grewal, S., & Bardwell, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510590200 · Cited by 36
Chronic over-nutrition and dysregulation of GSK3 in diseases
Liu, X., & Yao, Z. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0108-8 · Cited by 39
Xu, X., Chen, Y., Fu, Q., Ni, D., Zhang, J., Li, X., & Lu, S. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1553167 · Cited by 40
Posttranslational protein modifications
Clark, R. S. B., Bayır, H., & Jenkins, L. W. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000191712.96336.51 · Cited by 35
“For example, phospho-specific antibodies can be used to detect activation of specific kinases (5), proteolysis of specific protein targets can be used to track individual proteases (32), protein nitration and nitrosylation identifies elaboration of NO (21, 23), and poly(ADP-ribose) polymer– modified proteins reveal ac…”
BackgroundOh, E., Heise, C. J., English, J. M., Cobb, M. H., & Thurmond, D. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706591200 · Cited by 38
Cross-inhibitory activity of cereal protein inhibitors against α-amylases and xylanases
Sancho, A. I., Faulds, C. B., Svensson, B., Bartolomé, B., Williamson, G., & Juge, N. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(03)00209-7 · Cited by 35
Kliche, J., & Ivarsson, Y. (2022) · Biochemical Journal · doi:10.1042/bcj20200714 · Cited by 40
Itk tyrosine kinase substrate docking is mediated by a nonclassical SH2 domain surface of PLCγ1
Min, L., Joseph, R. E., Fulton, D. B., & Andreotti, A. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911309106 · Cited by 40
Linch, M., Sanz-García, M., Soriano, E., Zhang, Y., Riou, P., Rossé, C., Cameron, A., Knowles, P., Purkiss, A., Kjaer, S., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004068 · Cited by 33
Green, H. M., & Alberola‐Ila, J. (2005) · BMC Chemical Biology · doi:10.1186/1472-6769-5-1 · Cited by 39
“Elk1 and Ets1 were chosen because of their seemingly specific interaction with ERK relative to p38 or SAPK/JNK (reviewed in [ 18 ]).”
BackgroundStop the killer: how to inhibit the anthrax lethal factor metalloprotease
Montecucco, C. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.04.011 · Cited by 34
Involvement of small Ras GTPases and their effectors in chronic renal disease
Martínez‐Salgado, C., Rodríguez-Peña, A. B., & López-Novoa, J. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7260-2 · Cited by 39
Dettori, R., Sonzogni, S. V., Meyer, L., Lopez-Garcia, L. A., MORRICE, N. A., Zeuzem, S., Engel, M., Piiper, A., Neimanis, S., Frödin, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051151 · Cited by 35
Self-citationCallaway, K., Waas, W. F., Rainey, M. A., Ren, P., & Dalby, K. N. (2010) · Biochemistry · doi:10.1021/bi100199q · Cited by 32
Anthrax toxin: pathologic effects on the cardiovascular system
Honey, B. G. (2009) · Frontiers in bioscience · doi:10.2741/3382 · Cited by 33
“Recently, we and others have demonstrated that ET infusion results in early and pronounced decrements in mean arterial blood pressure and tachycardia, which leads to hypotension (72, 79).”
BackgroundSR Protein Kinase 1 Is Resilient to Inactivation
Ngo, J. C. K., Gullingsrud, J., Giang, K., Yeh, M. J., Fu, X., Adams, J. A., McCammon, J. A., & Ghosh, G. (2007) · Structure · doi:10.1016/j.str.2006.11.011 · Cited by 31
Regulation of tissue factor procoagulant activity by post-translational modifications
Egorina, E. M., Sovershaev, M. A., & Østerud, B. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2007.11.004 · Cited by 39
“Protein phosphorylation is performed by protein kinases, which represent one of the largest family of proteins within the human genome [25].”
BackgroundLi, D., Jackson, R. A., Yusoff, P., & Guy, G. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148445 · Cited by 48
Discovery of Novel Anticancer Therapeutics Targeting the Pi3K/Akt/Mtor Pathway
Maira, S.-M., Furet, P., & Stauffer, F. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.5 · Cited by 33
Sequence and Structure-Based Analysis of Specificity Determinants in Eukaryotic Protein Kinases
Bradley, D. T. C., Viéitez, C., Rajeeve, V., Selkrig, J., Cutillas, P. R., & Beltrão, P. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108602 · Cited by 33
Post-translational regulation of mitogen-activated protein kinase phosphatase-2 (MKP-2) by ERK
Dong, P., Zhou, J.-Y., & Wu, G. S. (2010) · Cell Cycle · doi:10.4161/cc.9.23.13957 · Cited by 30
“Sequence analysis indicated that MKP-2 contains an ERK binding domain, called DEF-domain, which is characterized by the sequence FxFP (F, Phenylalanine; x, any amino acid; P, proline).(25,26) The examination of primary structure of MKP-2 protein revealed several putative ERK1 and ERK2 phosphorylation sites, suggesting…”
BackgroundProteome-wide prediction of PKA phosphorylation sites in eukaryotic kingdom
Gao, X., Jin, C., Ren, J., Yao, X., & Xue, Y. (2008) · Genomics · doi:10.1016/j.ygeno.2008.08.013 · Cited by 38
“As described previously, only a short peptide flanking of a site is not sufficient for providing full specificity for a PK modification in vivo [19,20].”
BackgroundVandergaast, R., Mitchell, J. K., Byers, N. M., & Friesen, P. D. (2015) · Journal of Virology · doi:10.1128/jvi.03659-14 · Cited by 33
“To enhance specificity of kinase binding (45, 46), the TPxxS acceptor motif is typically preceded by a MAPK docking motif and followed by an FxF motif.”
BackgroundMethodZinc regulates the activity of kinase-phosphatase pair (BasPrkC/BasPrpC) in Bacillus anthracis
Arora, G., Sajid, A., Arulanandh, M. D., Misra, R., Singhal, A., Kumar, S., Singh, L. K., Mattoo, A. R., Raj, R., Maiti, S., et al. (2013) · BioMetals · doi:10.1007/s10534-013-9646-y · Cited by 28
“STPKs have evolved two properties essential for their function: the ability to recognize and phosphorylate their cognate substrates, and sensitive means of regulation (Biondi and Nebreda 2003).”
BackgroundStrategies for the NMR‐Based Identification and Optimization of Allosteric Protein Kinase Inhibitors
Jahnke, W., Blommers, M. J. J., Fernández, C. F., Zwingelstein, C., & Amstutz, R. (2005) · ChemBioChem · doi:10.1002/cbic.200500100 · Cited by 27
Liu, X. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-356 · Cited by 27
“Because GSK3 is constitutively activated (Biondi and Nebreda 2003), maintenance of PI3K/Akt activity is required for GSK3 inhibition and human health.”
BackgroundLee, S., Warthaka, M., Yan, C., Kaoud, T. S., Piserchio, A., Ghose, R., Ren, P., & Dalby, K. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018594 · Cited by 26
“For example, Extracellular signal-regulated kinase (ERK2) has two recruitment sites called the D-recruitment site (DRS) and the F-recruitment site (FRS) that bind D-sites and F-sites respectively [8].”
BackgroundMultiple implications of 3-phosphoinositide-dependent protein kinase 1 in human cancer
Li, Y., Yang, K.-J., & Park, J. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i8.239 · Cited by 29
Molecular imaging of c-Met tyrosine kinase activity
Zhang, L., Virani, S., Zhang, Y., Bhojani, M. S., Burgess, T. L., Coxon, A., Galbán, C. J., Ross, B. D., & Rehemtulla, A. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.01.028 · Cited by 26
Seong, H., Jung, H., Manoharan, R., & Ha, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.331827 · Cited by 25
“Recent studies suggest the involvement of docking interactions between protein kinases and their substrates for achieving substrate specificity and regulation of protein kinase activities (36).”
BackgroundPharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer
Balakrishnan, A., Vyas, A. K., Deshpande, K. S., & Vyas, D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2159 · Cited by 26
Tárrega, C., Ríos, P., Cejudo-Marín, R., Blanco‐Aparicio, C., van den Berk, L., Schepens, J. T. G., Hendriks, W. J. A. J., Tabernero, L., & Pulido, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504366200 · Cited by 26
The choreography of protein kinase PDK1 and its diverse substrate dance partners
Leroux, A. E., & Biondi, R. M. (2023) · Biochemical Journal · doi:10.1042/bcj20220396 · Cited by 25
Self-citationStructural and Dynamic Features of F-recruitment Site Driven Substrate Phosphorylation by ERK2
Piserchio, A., Ramakrishan, V., Wang, H., Kaoud, T. S., Arshava, B., Dutta, K., Dalby, K. N., & Ghose, R. (2015) · Scientific Reports · doi:10.1038/srep11127 · Cited by 19
Steady-state Kinetic Mechanism of PDK1
Gao, X., & Harris, T. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602448200 · Cited by 25
Salvi, M., Cesaro, L., & Pinna, L. A. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.013 · Cited by 23
“(7, 10, 11)x having, however, the big advantage of being simple and rather reliable as a predictive parameter whenever a sufficiently large number of bona fide phosphosites generated by the kinase of interest are already known.”
A herpesvirus kinase that masquerades as Akt
Chuluunbaatar, U., & Mohr, I. (2011) · Cell Cycle · doi:10.4161/cc.10.13.16242 · Cited by 24
Kinetic Mechanism and Inhibitor Characterization for c-jun-N-Terminal Kinase 3α1
Ember, B., Kamenecka, T., & LoGrasso, P. (2008) · Biochemistry · doi:10.1021/bi701852z · Cited by 22
Schmidt, M., Hofmann, H.-P., Sanders, K., Sczakiel, G., Beckers, T. L., & Gekeler, V. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0455 · Cited by 22
Adaptability in protein structures: structural dynamics and implications in ligand design
Maity, A., Majumdar, S., Priya, P., De, P., Saha, S., & Dastidar, S. G. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2013.873002 · Cited by 24
“The active forms of ERK2 can assure the interaction of nucleotide at both N- and C-terminal domains, which is consistent with its closed conformation, in contrary to its inactive form where the two domains are in an apparently open conformation.”
BackgroundKaushal, A., Myers, S., Dong, Y., Lai, J., Tan, O. L., Bui, L., Hunt, M. L., Digby, M. R., Samaratunga, H., Gardiner, R. A., et al. (2008) · The Prostate · doi:10.1002/pros.20685 · Cited by 21
“%) and contains consensus phosphorylation motifs for several kinases including MAPKs and CDKs [32] at each of the SP motifs at residues 2, 26, 37, and 70, and the serine/threonine kinaseGSK3b [33] at 19TSTLS and 70SPPGT (Fig.”
BackgroundChiu, T.-L., Solberg, J. C., Patil, S. P., Geders, T. W., Zhang, X., Rangarajan, S., Francis, R., Finzel, B. C., Walters, M. A., Hook, D. J., et al. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900186w · Cited by 21
Szafranska, A. E., & Dalby, K. N. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04827.x · Cited by 21
Inhibitors of anthrax lethal factor
Gaddis, B. D., Avramova, L. V., & Chmielewski, J. A. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.089 · Cited by 21
Docking-Dependent Regulation of the Rb Tumor Suppressor Protein by Cdk4
Wallace, M., & Ball, K. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5606-5619.2004 · Cited by 29
“Similarly, expression of Rb(1-886) in the Rb null CDK-deficient cell line Saos2, together with cyclin D1 and Cdk4, gave no pronounced change in mobility (Fig.”
BackgroundMethodInfluentialMaerz, S., Dettmann, A., & Seiler, S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06263-11 · Cited by 20
“Activation of AGC kinases also requires a second phosphorylation event or the permanent presence of an acidic residue in a hydrophobic motif that is located 45 to 60 residues C-terminal of the catalytic kinase domain in addition to phosphorylation of the activation loop (7, 33, 34).”
BackgroundHowng, S., Hwang, C., Hsu, C., Hsu, M.-Y., Teng, C.-Y., Chou, C., Lee, M.-F., Wu, C.-H., Chiou, S.-J., Lieu, A., et al. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0366-0 · Cited by 19
“catalytic core of kinase could also participate in the regulation of its activity [32–34].”
BackgroundKang, J., Toita, R., Oishi, J., Niidome, T., & Katayama, Y. (2007) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.08.002 · Cited by 18
“Protein phosphorylation is one of the most important post-translational modifications, as it regulates cellular functions through information processing [1–3].”
BackgroundFraser, J. A., & Hupp, T. R. (2007) · Biochemistry · doi:10.1021/bi061562j · Cited by 18
Host sequence motifs shared by HIV predict response to antiretroviral therapy
Dampier, W., Evans, P., Ungar, L., & Tozeren, A. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-47 · Cited by 16
“MAPK interacting molecules that carry this docking motif help to regulate specific interaction in the MAPK cascade [46,47].”
BackgroundExposure of protein kinase motifs that trigger binding of Hsp90 and Cdc37
Prince, T. L., & Matts, R. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.100 · Cited by 18
Metadata
- Authors
- BIONDI, R. M., & NEBREDA, A. R.
- Affiliations
- University of Dundee (GB)
- European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany
- ORCID
- BIONDI, Ricardo M.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2003-05-15
- Volume
- 372
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1223382
- OpenAlex
- W2049277771
- Cited by
- 334
- References
- 142
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 7 · 2020: 8 · 2019: 6 · 2018: 6 · 2017: 5 · 2016: 9 · 2015: 11 · 2014: 13 · 2013: 14 · 2012: 15
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GlaxoSmithKline
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- serine/threonine kinase, substrate specificity, docking site, protein kinase signalling, MAPK family, glycogen synthase kinase-3, phosphoinositide-dependent protein kinase 1, AGC kinases, kinase regulation, hydrophobic motif
- MeSH terms
- Animals, Binding Sites, Humans, Insulin, Phosphorylation, Proto-Oncogene Proteins, Transcription Factors, Signal Transduction, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Mitogen-Activated Protein Kinases, Zebrafish Proteins, Glycogen Synthase Kinase 3, Wnt Proteins, 3-Phosphoinositide-Dependent Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.